Table 5 Summarized key findings.

From: Intraventricular antibiotics for severe central nervous system infections: a case series

 

Overall

CA-CNSI

HAVM

p-Value

Age (as years, mean (SD))

54.1 (15.6)

47.9 (16.2)

59.9 (13.1)

0.045

Microbiology

   

0.009

Not identified* (n (%))

3 (11.1)

0 (0.0)

3 (21.4)

 

Gram-positive (n (%))

12 (44.4)

9 (69.2)

3 (21.4)

 

Gram-negative (n (%))

8 (29.6)

1 (7.7)

7 (50.0)

 

Mixed flora (n (%))

4 (14.8)

3 (23.1)

1 (7.1)

 

mRS at discharge

   

0.525

No symptoms (n (%))

0 (0.0)

0 (0.0)

0 (0.0)

 

No significant disability (n (%))

1 (3.7)

1 (7.7)

0 (0.0)

 

Slight disability (n (%))

4 (14.8)

3 (23.1)

1 (7.1)

 

Moderate disability (n (%))

4 (14.8)

2 (15.4)

2 (14.3)

 

Moderate-severe disability (n (%))

4 (14.8)

1 (7.7)

3 (21.4)

 

Severe disability (n (%))

9 (33.3)

3 (23.1)

6 (42.9)

 

Death (n (%))

5 (18.5)

3 (23.1)

2 (14.3)

 

CSF- WBC at Diagnosis (median [25th percentile – 75th percentile])

682 [246 – 2′944]

1181 [685 – 66′410]

346 [176 – 1′819]

0.221

CSF-WBC at IVT Initiation (median [25th percentile – 75th percentile])

596 [69 – 1′920]

511 [91 – 1′827]

680 [76 – 2′659]

0.606

  1. Key findings from the comparisons between patients with community-acquired central nervous system infections (CA-CNSI) and healthcare-associated ventriculitis and meningitis (HAVM) are summarized in this table. mRS: modified Rankin scale. CSF- WBC: cerebrospinal fluid white blood cell count.